These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6978586)
1. [Immunomodulating action of levamisol preparation in the treatment of trichinellosis (author's transl)]. Szadkowska D; Boroń P; Borzuchowska A; Prokopowicz D; Boroń-Kaczmarska A Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):273-8. PubMed ID: 6978586 [TBL] [Abstract][Full Text] [Related]
2. The study of T-lymphocytes, granulocyte's phagocytic activity, and adherent cells in patients with acute lymphoblastic leukemia during levamisol therapy. Bogusławska-Jaworska J; Chybicka A; Pisarek J Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):855-8. PubMed ID: 312090 [TBL] [Abstract][Full Text] [Related]
3. Levamisole in the treatment of Hodgkin's disease. Berényi E; Kávai M; Szabolcsi M; Szegedi G Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549 [TBL] [Abstract][Full Text] [Related]
4. [The dynamics of humoral and cellular immunity changes in patients with acute phase of trichinellosis (author's transl)]. Boroń-Kaczmarska A; Boroń P; Borzuchowska A; Prokopowicz D; Bobrowska-Sokolewicz E; Wyrzykowski J Zentralbl Bakteriol Orig A; 1979; 245(3):387-94. PubMed ID: 44794 [TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of the use of levamisole and pyrogenal in the treatment of multiple sclerosis]. Mukhtarova AA Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):366-7. PubMed ID: 3873154 [TBL] [Abstract][Full Text] [Related]
6. The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis. Rosenthal M; Trabert U; Müller W Clin Exp Immunol; 1976 Sep; 25(3):493-6. PubMed ID: 1085681 [TBL] [Abstract][Full Text] [Related]
7. Some T-cell functions in patients with viral myocarditis. The effect of levamisole. Goch JH; Czernicki J; Offierska M Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):395-404. PubMed ID: 6223612 [TBL] [Abstract][Full Text] [Related]
8. [Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients]. Borisova AM; Novikova TA; Glazko AV Ter Arkh; 1984; 56(10):29-31. PubMed ID: 6335306 [TBL] [Abstract][Full Text] [Related]
9. [Levamisol in the treatment of recurrent urinary tract infections]. Lubetkin AM; Remedi RF; Granero M; Brarda O Bol Med Hosp Infant Mex; 1979; 36(6):1109-12. PubMed ID: 385017 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of immunocompetent cell subpopulations in chronic bronchitis patients during the use of different immunomodulating preparations]. Karaulov AV; Sil'vestrov VP; Martsinovskiĭ VIu; Bulycheva NA; Likov VF Ter Arkh; 1984; 56(10):14-7. PubMed ID: 6335305 [TBL] [Abstract][Full Text] [Related]
11. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole]. Markova TP; Danilova NV Ter Arkh; 1985; 57(7):15-8. PubMed ID: 3876611 [TBL] [Abstract][Full Text] [Related]
12. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome. Czekalski S; Sulima D; Strzelecka G Proc Eur Dial Transplant Assoc; 1983; 19():800-3. PubMed ID: 6603617 [TBL] [Abstract][Full Text] [Related]
13. [Study of peripheral blood T-lymphocytes by the spontaneous and active "rosette" method using levamisole]. Liapon AO; Lebedev KA; Mashkilleĭson AL Biull Eksp Biol Med; 1980 May; 89(5):630-2. PubMed ID: 6967335 [TBL] [Abstract][Full Text] [Related]
14. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations. Pozsonyi T; Fehér J; Jakab L Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266 [TBL] [Abstract][Full Text] [Related]
15. Levamisole treatment of recurrent spastic bronchitis in children--the effect on selected parameters of immunologic and hemostatic systems. Prusek W; Wieczorek E; Podwysocka M; Maćkowiak J Arch Immunol Ther Exp (Warsz); 1985; 33(6):803-9. PubMed ID: 3914252 [TBL] [Abstract][Full Text] [Related]
16. [Use of the immunomodulator levamisole in the complex treatment of juvenile schizophrenics with an unfavorable course]. Mikheeva TV; Sekirina TP; Abramova LI; Koliaskina GI; Tsutsul'kovskaia MIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(1):109-13. PubMed ID: 2881414 [TBL] [Abstract][Full Text] [Related]
17. Change in immune response in children suffering from opisthorchosis and attempt at its correction using Levamisol. Kashuba EA; Krylov VI J Hyg Epidemiol Microbiol Immunol; 1984; 28(3):345-52. PubMed ID: 6491276 [TBL] [Abstract][Full Text] [Related]
18. Partial review of immunotherapeutic pharmacology in stem cell transplantation. Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081 [TBL] [Abstract][Full Text] [Related]
19. [Experimental study on levamisole modulation of antitumor immunity--1]. Saji S; Ooshita H; Adachi Y; Yamamoto S; Takekoshi T; Sakata K Gan To Kagaku Ryoho; 1982 Aug; 9(8):1418-26. PubMed ID: 6985198 [TBL] [Abstract][Full Text] [Related]
20. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)]. Miyake M Fukuoka Igaku Zasshi; 1981 Jun; 72(6):368-78. PubMed ID: 6975743 [No Abstract] [Full Text] [Related] [Next] [New Search]